logo
Canada's TD Bank profit falls on hit from higher bad loan provisions

Canada's TD Bank profit falls on hit from higher bad loan provisions

Reuters22-05-2025
May 22 (Reuters) - TD Bank (TD.TO), opens new tab reported a fall in second-quarter profit on Thursday, as the Canadian lender stockpiled money to cover for potential bad loans in an uncertain economic environment.
The results from the country's second-biggest bank offer a glimpse into the impact of the tariff chaos on the Canadian economy. Trade uncertainty is expected to result in higher credit losses and weaker loan growth as sentiment takes a hit from the changing outlook.
In the second quarter, TD's provision for credit losses jumped to C$1.34 billion ($965.5 million) from C$1.07 billion a year earlier.
"TD delivered strong results this quarter, with robust trading and fee income in our markets-driven businesses as well as deposit and loan growth in Canadian Personal and Commercial Banking," CEO Raymond Chun said in a statement.
"We are operating in a fluid macroeconomic environment," Chun said.
TD is also undergoing a broad-based strategic review as the new leadership looks to simplify the business and turnaround the bank after its anti-money laundering problems. Chun, a longtime TD Bank executive, took the helm in February.
Meanwhile, TD's wholesale banking arm - which houses its capital markets and investment banking businesses - reported record revenue of C$2.13 billion, a 10% jump from a year earlier.
Uncertainty stemming from U.S. trade policy injected heightened market volatility, spurring trading activity as investors aggressively rejigged their portfolios.
Among transactions in the quarter, TD Securities was the lead left bookrunner on the $13.1 billion secondary offering of Charles Schwab (SCHW.N), opens new tab shares by TD, one of the largest equity market deals ever.
TD kicks off the earnings season for Canadian lenders, with rival big banks set to report their results next week.
The bank posted adjusted net income of C$3.63 billion, or C$1.97 per share, for the three months ended April 30, compared with C$3.79 billion, or C$2.04 per share, a year earlier.
TD shares have gained 17.5% this year, outperforming rival banks.
($1 = 1.3878 Canadian dollars)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US private payrolls increase in July
US private payrolls increase in July

Reuters

time15 minutes ago

  • Reuters

US private payrolls increase in July

WASHINGTON, July 30 (Reuters) - U.S. private payrolls increased more than expected July, the ADP National Employment Report showed on Wednesday, though the labor market continues to slow. Private payrolls rose by 104,000 jobs last month after a revised 23,000 decline in June. Economists polled by Reuters had forecast private employment increasing 75,000 following a previously reported drop of 33,000 in June. The ADP report, jointly developed with the Stanford Digital Economy Lab, was published ahead of the more comprehensive employment report for July due to be released on Friday by the Labor Department's Bureau of Labor Statistics. There is no correlation between the ADP and BLS employment reports. The labor market has lost steam amid an unsettled economic outlook stemming from import tariffs. A survey from the Conference Board on Tuesday showed the share of consumers viewing jobs as "hard" to get jumped to the highest level in nearly 4-1/2 years in July. That is consistent with the high number of people collecting unemployment checks. A Reuters survey of economists expects the BLS' employment report to show nonfarm payrolls increased by 110,000 jobs in July after rising by 147,000 in June. The unemployment rate is forecast to increase to 4.2% from 4.1% in June. Economists expect the Federal Reserve will keep its benchmark interest rate in the 4.25%-4.50% range after the end of a two-day policy meeting later on Wednesday, resisting pressure from President Donald Trump to lower borrowing costs. The Fed cut rates three times in 2024, with the last move coming in December.

EU trade deal will take a toll on German economy, minister says
EU trade deal will take a toll on German economy, minister says

Reuters

time17 minutes ago

  • Reuters

EU trade deal will take a toll on German economy, minister says

BERLIN, July 30 (Reuters) - German Finance Minister Lars Klingbeil is dissatisfied with the European Union's trade deal with the United States, as he thinks it will take a toll on Germany' economic growth, he said on Wednesday. "I have no illusions about it, it is rather growth-weakening," Klingbeil said in the presentation of the 2026 draft budget, lamenting that the EU was "too weak" in the negotiations. The U.S. struck a framework trade agreement with the EU on Sunday, imposing a 15% import tariff on most EU goods. "I would have wished for a different outcome," Klingbeil said. "Still, all in all, it is good that there is an agreement with the U.S., that there are no further escalations."

Opinion: Britain needs a tax break
Opinion: Britain needs a tax break

Daily Mail​

time17 minutes ago

  • Daily Mail​

Opinion: Britain needs a tax break

Aspiration is terrific, but Labour's bravado about Britain being the fastest growing economy in the G7 was always hooey. Economic output is trivialised if assessed as a sports league table. Any growth at all is welcome in an uncertain world of tariffs, fragmentation and geopolitical turmoil. Raising taxes by £40billion and piling much of the cash into the public sector without productivity targets was a nonsense. Worse, the surcharge on employers' National Insurance (NI) contributions and levies on wealth penalised jobs, work and enterprise. Latest forecasts from the International Monetary Fund (IMF) show that UK growth at 1.2 per cent this year and 1.4 per cent next will lag that of the US and Canada. Despite nostalgia in some quarters for a return to the European Union, the UK's fleet-of-foot services-led economy outpaces Germany and France. The IMF has upgraded forecasts for global output this year and in 2026. In April, the Fund's projections were overshadowed by Liberation Day tariffs. But Britain, Japan, India and the EU have limited damage. The US and China are still working on a deal so, critically, a new era of beggar-thy-neighbour retaliatory actions has been averted. The brakes on globalisation have been applied. Data from Yale University's Budget Lab shows that, after the EU deal, the average tariff for goods entering the US will be 17.3 per cent, the highest since the 1930s. There is no mystery as to Donald Trump's remedy for dealing with stuttering growth. As master instructed pupil Keir Starmer in Scotland this week, the best way forward is lower taxes. Lessons of October 2024 must be learned. Every tax increase outlined, from NI and capital gains to inheritance and stamp duties on lower priced homes, stymied commerce. Simple changes to the tax system could help. Abolishing stamp duty on share trading would boost listings and confidence. Including digital expenditure in full expensing of capital spending could light a fire under AI and biotech. As wonderful as reviving tin production in Cornwall may be, spending money on an AstraZeneca plant just might have averted the pharma giant's American tilt. Captain America AstraZeneca boss Pascal Soriot has good reason to look across the Atlantic. A knighthood is one kind of recognition. But Keir Starmer's government has still to come up with a credible pharma strategy. A fixation on steel, car making and renewables has left medicines, one of Britain's most dynamic industries, in the lurch. Soriot remains tight-lipped on a move of Britain's largest listed company to New York. His current enthusiasm for America shows no bounds. A £37billion US investment strategy and a promise of local manufacturing is his ace card. AstraZeneca has two world class R&D centres and a workforce of close to 20,000 in America. It has good reason to double down on a market which represents 40 per cent of sales. Speaking to CNBC, the Astra boss also praised the US for its science and innovation. There was barely a mention of home territories in the UK and Sweden. AZ's pipeline of oncology drugs is as strong as ever with sales up 15 per cent at £9billion, contributing almost half of total revenues in the first half of the year. Next on the agenda for Soriot is an oral compound designed to take on leaders Novo Nordisk and Eli Lilly on weight loss. He believes that his company can deliver Americans an oral medicine at a cheaper price than rivals. The meltdown in first mover Novo Nordisk's share price suggests investors believe the weight loss tortoise could, eventually, catch the hare. Trading places Barclays is thriving despite a reputational hit from the Jes Staley-Epstein relationship. Goldman Sachs looks to be cooling off on the UK. But Barclays retains its place as Europe's most influential investment bank. It is a big beneficiary of volatility since Liberation Day with profits climbing by 23 per cent on the back of an industry beating 26 per cent gain on fixed interest, currencies, and commodity trading. As chief executive Venkat reiterated, success should not be an excuse for Labour to clobber banks with more tax.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store